Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting treatment in AML.

Hematology. American Society of Hematology. Education Program - 1 Jan 2007

Burnett Alan K, Knapper Steve

Abstract excerpt

Currently available chemotherapy has probably reached the limits of its potential in treating acute myeloid leukemia (AML). In considering the next steps it is appropriate to exploit on the one hand knowledge of the molecular, immunophenotypic and biological characteristics of the disease and on the other the biology of the patient. The aim is to move towards a more targeted approach. Immunophenotyping has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Drug Delivery Systems
Share to Immunohistochemistry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Mice, Inbred NOD

Share to Mice, SCID

Share to Neoplasm, Residual

Source

Identifiers

PMID: 18024661
DOI: 10.1182/asheducation-2007.1.429

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting treatment in AML.PMID 18024661Read ↗

Molecularly targeted therapy in acute myeloid leukemia.Semantic proximity Read ↗

Molecular targeting in acute myeloid leukemiaSemantic proximity Read ↗

Targeted therapy of acute myeloid leukemia in 2012: towards individualized therapy.Semantic proximity Read ↗

Acute myeloid leukemia: advancing clinical trials and promising therapeutics.Semantic proximity Read ↗

Targeted therapies in myeloid leukemias.Semantic proximity Read ↗

New developments in the treatment of acute myeloid leukemia.Semantic proximity Read ↗

Molecularly targeted therapy in acute myeloid leukemia.Semantic proximity Read ↗

New strategies for the treatment of acute myeloid leukemia including antibodies and other novel agents.Semantic proximity Read ↗

Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199.Semantic proximity Read ↗

New agents for the treatment of acute myeloid leukemia.Semantic proximity Read ↗

Targeting FLT3 for the treatment of leukemia.Semantic proximity Read ↗

FLT3 Inhibitors in AML: Are We There Yet?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.